Whole-blood del Nido versus Cold Modified del Nido for Myocardial Protection

Tepid Whole-blood del Nido versus Cold Modified del Nido Cardioplegia for Myocardial Protection in adults undergoing elective cardiac surgery with cardiopulmonary bypass: Randomized Control Trail (RCT)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310853438175

Enrollment

Registered

2023-10-11

Start date

2023-10-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiology Anaesthesia

Interventions

Tepid Whole blood del Nido Cardioplegia

Cold modified del Nido

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients referred for elective valve replacement surgery, ASD, VSD, or coronary artery bypass grafting surgery, or combined elective surgery - ASA classification II & III.

Exclusion criteria

Exclusion criteria: Preoperative hemoglobin level < 12.0 g/dL Severe pulmonary hypertension Preoperative uncontrolled diabetes, Chronic renal failure requiring hemodialysis Poor left ventricular function (ejection fraction <30%) Preoperatively on intra-aortic balloon pump Patients with recent acute coronary syndrome Emergency procedures and Endocarditis Inability or unwillingness to give informed consent for participation.

Design outcomes

Primary

Measure	Time frame
Troponin I enzyme;CK-MB;Need for Defibrillation	—

Secondary

Measure	Time frame
Need for blood transfusion;Duration of inotropes	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026